Regeneron Pharmaceuticals Inc at Oppenheimer Healthcare Life Sciences Conference Transcript
Great. Thank you, everybody, for joining us on the second day here of this track with the Oppenheimer Healthcare Conference of 2024. Got David Snow, the SVP and the Global Head of Dupixent franchise and Ryan Crowe, the SVP of IR joining us here giving us a presentation, which I'm really looking forward to. Regeneron has been always a constant supporter of ours at our healthcare conferences. Really appreciate having them back.
David will give us an update on DUPIXENT. And then from there, we can jump into our fireside chat or just an overall update on the franchise, and we can jump into the fireside chat after that. So please take it away.
Thank you, Hartaj and always great to be a part of the Oppenheimer Healthcare Conference, and Happy Valentine's Day to everybody out there.
Just do a quick forward-looking statement, and then I'll hand it over to David for some opening remarks before we get to Hartaj's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
